Elevance buys, then adds specialty pharmacy BioPlus to its PBM

Elevance Health Inc. announced it has closed its deal to acquire specialty pharmacy BioPlus, after first announcing the buy in November 2022, reports Healthcare Dive. BioPlus focuses on complex and chronic conditions like cancer and multiple sclerosis and has a footprint that “touches all 50 states,” according to the insurer’s announcement. With the buy, for an undisclosed amount, BioPlus will now operate as a part of Elevance’s pharmacy benefit manager, CarelonRx.